GSK’s Shingrix Vaccine Can Reach Millions More
US FDA Clears New Claim In Immunocompromised Adults
The shingles vaccine could potentially be used in about three million immunocompromised people, according to GSK, but CDC’s advisory committee will weigh in with recommendations.
